Newsroom

Sorted by: Latest

-

MRM Health krijgt Fast Track-status van de Amerikaanse FDA voor MH002 voor de behandeling van mild tot matig actieve colitis ulcerosa

GENT, België--(BUSINESS WIRE)--MRM Health, een biotechbedrijf in de klinische ontwikkelingsfase dat therapieën ontwikkelt voor immuungemedieerde aandoeningen en de kracht van het microbioom benut om het immuunevenwicht te herstellen, heeft vandaag bekendgemaakt dat MH002, de leidende rationeel ontworpen kandidaat binnen de categorie Live Biotherapeutic Products (LBP) van het bedrijf, door de Amerikaanse Food and Drug Administration (FDA) de Fast Track-status heeft gekregen voor de behandeling v...
-

MRM Health obtient la désignation Fast Track de la FDA américaine pour MH002 dans la rectocolite hémorragique légère à modérée

GAND, Belgique--(BUSINESS WIRE)--MRM Health, une sociéte de biotechnologie en phase clinique développant des thérapies pour les maladies à médiation immunitaire et exploitant le potentiel du microbiome afin de restaurer l’équilibre immunitaire, a annoncé aujourd’hui que le MH002, principal candidat du portefeuille et produit biothérapeutique vivant (Live Biotherapeutic Product, LBP) conçu de manière rationnelle, s’est vu accorder la désignation Fast Track par la Food and Drug Administration (FD...
-

MRM Health erhält Fast-Track-Status der US-amerikanischen FDA für MH002 zur Behandlung von leichter bis mittelschwerer aktiver Colitis ulcerosa

GENT, Belgien--(BUSINESS WIRE)--MRM Health, ein biopharmazeutisches Unternehmen mit Produkten in klinischen Entwicklungsstadien, das Therapeutika für immunvermittelte Erkrankungen entwickelt, die das Potenzial des Mikrobioms zur Wiederherstellung des Immungleichgewichts nutzen, gab heute bekannt, dass sein Leitprogramm MH002, ein rational konzipiertes mikrobiombasiertes biotherapeutisches Produkt („Live Biotherapeutic Product", LBP), von der US-amerikanischen Food and Drug Administration (FDA)...
-

AM Best Affirms Credit Ratings of Tokio Marine GRV Re, Inc.

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) of Tokio Marine GRV Re, Inc. (TMGRV Re) (Oklahoma City, OK). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect TMGRV Re’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, limited business profile and very strong enterprise risk management (ERM). The company...
-

Hamilton Reports 2026 First Quarter Results

PEMBROKE, Bermuda--(BUSINESS WIRE)--Hamilton Insurance Group, Ltd. (NYSE: HG; “Hamilton” or the “Company”) today announced financial results for the first quarter ended March 31, 2026. Commenting on the results, Pina Albo, CEO of Hamilton, said: “Hamilton reported strong first quarter 2026 results, generating net income of $134 million and operating income of $167 million, an annualized return on average equity of 19% and operating return on average equity of 24%. This was supported by a 89.8%...
-

MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis

GHENT, Belgium--(BUSINESS WIRE)--MRM Health, a clinical-stage biopharmaceutical company developing therapeutics for immune-mediated diseases, which unlock the power of the microbiome to restore immune balance, today announced that MH002, the Company’s lead rationally designed Live Biotherapeutic Product (LBP) candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate ulcerative colitis (UC). MH002 today is the most adv...
-

AIG Reports Excellent First Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--American International Group, Inc. (NYSE: AIG) today reported financial results for the first quarter ended March 31, 2026. “AIG entered 2026 with significant momentum and delivered outstanding first quarter results, highlighting the strength of our underwriting capabilities and sustained earnings momentum across our businesses. The adjusted after-tax income per diluted share was $2.11 for the quarter, an 80% increase year-over-year, and Core Operating ROE was 12.2%,”...
-

MasTec Reports First Quarter 2026 Results and Increases Full Year 2026 Financial Guidance

CORAL GABLES, Fla.--(BUSINESS WIRE)--MasTec, Inc. (NYSE: MTZ) today announced first quarter 2026 financial results and increased full year 2026 financial guidance. "We are pleased to report that first quarter financial performance posted strong double-digit year-over-year growth in both revenue and profitability, while also exceeding guidance in all respects as MasTec continues to execute on very strong customer demand across all of our end-markets," said Jose Mas, MasTec's Chief Executive Offi...
-

Pacific Coast Oil Trust Announces Monthly Net Profits Interest Calculations

HOUSTON--(BUSINESS WIRE)--PACIFIC COAST OIL TRUST (OTC–ROYTL) (the “Trust”), a royalty trust formed by Pacific Coast Energy Company LP (“PCEC”), announced today that there will be no cash distribution to the holders of its units of beneficial interest of record on April 27, 2026 based on the Trust’s calculation of net profits generated during February 2026 (the “Current Month”) as provided in the conveyance of net profits interests and overriding royalty interest (the “Conveyance”). As further...
-

JBG SMITH Declares a Quarterly Common Dividend of $0.175 Per Share

BETHESDA, Md.--(BUSINESS WIRE)--JBG SMITH (NYSE: JBGS), a leading owner, operator, and developer of mixed-use properties in the Washington, DC market, today announced that its Board of Trustees has declared a quarterly dividend of $0.175 per common share. The dividend will be paid on May 28, 2026 to common shareholders of record as of May 14, 2026. About JBG SMITH JBG SMITH owns, operates, and develops mixed-use properties concentrated in amenity-rich, Metro-served submarkets in and around Wash...